Forever Labs
Forever Labs collects and cryo-preserves adult stem cells in an FDA-compliant biorepository, ensuring that individuals have access to their younger, more effective stem cells for future medical therapies. This process addresses the decline in stem cell quantity and functionality associated with aging, preserving a vital resource for potential treatments of age-related diseases.
- Biotechnology
Funding
Raised to date
$2.9MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
- Source unavailable
- siliconbadia.com (opens in a new tab)investor website
- Source unavailable
Founders
Product
Problem
As people age, the quantity and quality of their stem cells decline, reducing the body's ability to repair and regenerate tissues, potentially leading to age-related diseases and reduced lifespan. Accessing younger, more effective stem cells for future therapies is limited.
Solution
Forever Labs provides adult stem cell banking services, collecting and cryopreserving stem cells for potential use in future regenerative medicine therapies. The company partners with physicians to collect stem cells via a minimally invasive outpatient procedure. Collected stem cells are then cryogenically frozen and stored in an FDA-compliant biorepository. This process preserves the cells at their current age, banking a supply of younger, more potent stem cells for future treatments of age-related diseases and potential rejuvenation therapies.
Target Audience
The primary target audience includes adults aged 20-60 who are interested in proactive health management, longevity, and potential future regenerative medicine therapies using their own stem cells.
Features
- Stem cell collection performed by partner physicians
- Cryopreservation in an ISO 20387 accredited lab
- Long-term storage in an FDA-compliant, clinical-grade biorepository
- Annual and lifetime storage plan options
- Option to participate in stem cell research programs
- Anonymized data sharing with research institutions to study therapies for age-related diseases